Noradrenergic mediation of traumatic spinal cord autodestruction.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D002415:Cats; D004220:Disulfides / Q000494:pharmacology; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors; D006470:Hemorrhage / Q000378:metabolism; D007093:Imidazoles / Q000494:pharmacology; D008750:Methyldopa / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D008856:Microscopy, Fluorescence; D009336:Necrosis; D009638:Norepinephrine / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011984:Sensory Receptor Cells; D013050:Spectrometry, Fluorescence; D013116:Spinal Cord / Q000166:cytology / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D013119:Spinal Cord Injuries / Q000378:metabolism*; D013881:Thioridazine / Q000494:pharmacology; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D004220:Disulfides; D007093:Imidazoles; D008781:Methyltyrosines; D010643:Phenoxybenzamine; D008750:Methyldopa; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D002262:Carboxy-Lyases; D001058:Apomorphine; D013881:Thioridazine; D009638:Norepinephrine